A single-center retrospective study evaluating the safety and feasibility of ultrasound-guided T-VEC injection in patients with advanced melanoma
Latest Information Update: 06 Aug 2021
At a glance
- Drugs Talimogene laherparepvec (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions
Most Recent Events
- 06 Aug 2021 New trial record